Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.

Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6341-6.

2.

Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK).

Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S.

Biochem Biophys Res Commun. 1998 Apr 17;245(2):337-43.

PMID:
9571151
4.

Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).

Gustafsson MO, Hussain A, Mohammad DK, Mohamed AJ, Nguyen V, Metalnikov P, Colwill K, Pawson T, Smith CI, Nore BF.

Mol Cell Biol. 2012 Jul;32(13):2440-53. doi: 10.1128/MCB.06620-11. Epub 2012 Apr 23.

5.

Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.

Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun FM.

J Biol Chem. 1999 Jan 15;274(3):1646-56.

6.

The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS.

Guinamard R, Fougereau M, Seckinger P.

Scand J Immunol. 1997 Jun;45(6):587-95.

7.

Phosphorylation of Bruton's tyrosine kinase by c-Abl.

Bäckesjö CM, Vargas L, Superti-Furga G, Smith CI.

Biochem Biophys Res Commun. 2002 Dec 6;299(3):510-5. Erratum in: Biochem Biophys Res Commun. 2003 Jan 31;301(1):259.

PMID:
12445832
8.

A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.

Tomlinson MG, Woods DB, McMahon M, Wahl MI, Witte ON, Kurosaki T, Bolen JB, Johnston JA.

BMC Immunol. 2001;2:4. Epub 2001 Jun 8.

9.

Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11526-33.

10.

Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway.

Baba Y, Nonoyama S, Matsushita M, Yamadori T, Hashimoto S, Imai K, Arai S, Kunikata T, Kurimoto M, Kurosaki T, Ochs HD, Yata Ji, Kishimoto T, Tsukada S.

Blood. 1999 Mar 15;93(6):2003-12.

11.

Regulation of Btk function by a major autophosphorylation site within the SH3 domain.

Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP, Witte ON.

Immunity. 1996 May;4(5):515-25.

13.

Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase.

Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB.

Mol Cell Biol. 1995 Oct;15(10):5304-11.

14.

BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.

Yang W, Desiderio S.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):604-9.

15.

Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.

Qin S, Chock PB.

Biochemistry. 2001 Jul 10;40(27):8085-91.

PMID:
11434777
16.

BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells.

Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T.

Science. 1996 Aug 23;273(5278):1096-100.

PMID:
8688094
17.

Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.

Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW.

J Immunol. 2003 Dec 1;171(11):5988-96.

18.
19.

Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.

Sacristán C, Tussié-Luna MI, Logan SM, Roy AL.

J Biol Chem. 2004 Feb 20;279(8):7147-58. Epub 2003 Nov 17.

20.

Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.

Mohamed AJ, Yu L, Bäckesjö CM, Vargas L, Faryal R, Aints A, Christensson B, Berglöf A, Vihinen M, Nore BF, Smith CI.

Immunol Rev. 2009 Mar;228(1):58-73. doi: 10.1111/j.1600-065X.2008.00741.x. Review.

PMID:
19290921

Supplemental Content

Support Center